Sufentanil

Generic Name: Sufentanil

Brand Names: Dsuvia, Sufenta, Dzuveo

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₃₀N_₂O_₂S

CAS Number: 56030-54-7

Unique Ingredient Identifier: AFE2YW0IIZ

Background: Sufentanil is an opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent. It is administered by the intravenous, epidural and sublingual routes.
...

Indication: The indications for this drug are as follows:

Associated Conditions: Acute Pain, Severe Acute Pain

Associated Therapies: General Anesthesia, Induction and Maintenance of General Anesthesia, Lumbar epidural anesthesia therapy, Short opioid analgesia requirement

Clinical Trials

Evaluation of the Efficacy of VR on Pain and Anxiety When Performing an Ultrasound-controlled Ankle Block.

Not Applicable

Completed

Conditions: Hallux Valgus
Surgery

Interventions: Device: Virtual reality
Drug: Droleptan
Drug: Propofol
Drug: Sufentanyl

First Posted Date: 2018-09-19

Last Posted Date: 2019-03-26

Lead Sponsor: Clinique Saint Jean, France

Target Recruit Count: 60

Registration Number: NCT03677323

Locations: 🇫🇷
Clinique Saint Jean, Montpellier, France

The Effect and Safety of the Four Points Transversus Abdominis Plane Block

Not Applicable

Completed

Conditions: Adult Disease
Liver Diseases

Interventions: Procedure: TAP
Procedure: PVB
Drug: Ropivacaine
Drug: Sufentanil

First Posted Date: 2018-07-26

Last Posted Date: 2021-01-12

Lead Sponsor: Gia Dinh People Hospital

Target Recruit Count: 30

Registration Number: NCT03598192

Locations: 🇻🇳
Binh Huynh, Ho Chi Minh City, Ho Chi Minh, Vietnam

Observational Study of Analgesia and Cost-efficiency of Analgetic Medication Pumps (Zalviso and PCA-syringe Pump (PCA=Patient Controlled Analgesia)) After Urogenital Intervention at the Clinical Daily Routine

Conditions: Mobility
Analgesic Quality

Interventions: Drug: Sufentanil

First Posted Date: 2017-11-28

Last Posted Date: 2017-11-28

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 100

Registration Number: NCT03355352

Locations: 🇩🇪
University Tuebingen, clinic of anästhesiology and intensiv care, Tuebingen, Germany

Effect of Epidural Opioid Administered in the First A Period on the Progress of Labour

Phase 4

Conditions: Anesthesia, Epidural
Labor Pain
Opioid

Interventions: Drug: Sufentanil
Drug: Fentanyl

First Posted Date: 2017-11-17

Last Posted Date: 2018-12-06

Lead Sponsor: Medical University of Warsaw

Target Recruit Count: 300

Registration Number: NCT03344042

Locations: 🇵🇱
Uniwersyteckie Centrum Zdrowia Kobiety i Noworodka, WUM, Warszawa, Mazowieckie, Poland

Intranasal Sufentanil Versus Intravenous Morphine for the Management of Acute Pain

Phase 4

Conditions: Acute Pain

Interventions: Drug: Sufentanil
Drug: Normal saline
Drug: Morphine

First Posted Date: 2017-07-21

Last Posted Date: 2017-07-21

Lead Sponsor: The Brooklyn Hospital Center

Target Recruit Count: 40

Registration Number: NCT03224039

Locations: 🇺🇸
The Brooklyn Hospital Center, Brooklyn, New York, United States

The Hemodynamic Effect Between Two Types of Anesthesia in Esophageal Surgery

Not Applicable

Completed

Conditions: Epidural Block
Oesophageal Cancer
Oesophagectomy

Interventions: Other: paravertebral block
Other: thoracic epidural block
Drug: ropivacaine
Drug: Sufentanil

First Posted Date: 2017-06-14

Last Posted Date: 2017-06-14

Lead Sponsor: University Hospital, Lille

Target Recruit Count: 54

Registration Number: NCT03185403

Locations: 🇫🇷
CHRU , Hôpital Claude Huriez, Lille, France

Postoperative Analgesia in Patients With Microvascular Decompression

Phase 4

Conditions: Trigeminal Neuralgia

Interventions: Other: scalp nerve block
Drug: Ketamine
Drug: ondansetron
Drug: Sufentanil

First Posted Date: 2017-05-15

Last Posted Date: 2018-05-15

Lead Sponsor: Xiangya Hospital of Central South University

Target Recruit Count: 90

Registration Number: NCT03152955

Locations: 🇨🇳
Xiangya Hospital of Central South University, Changsha, Hunan, China

The Epigenetic Modification in OPRM1 on Postoperative Analgesia and Side Effect Induced by Sufentanil

Phase 4

Conditions: Epigenetics

Interventions: Drug: Sufentanil
Drug: dexmedetomidine
Drug: propofol
Drug: Rocuronium
Drug: sevoflurane
Drug: remifentanil
Drug: Parecoxib

First Posted Date: 2017-05-01

Last Posted Date: 2017-05-01

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 100

Registration Number: NCT03135795

Locations: 🇨🇳
Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia

Not Applicable

Completed

Conditions: Pain
Anesthesia

Interventions: Drug: Normal saline
Drug: Remifentanil
Drug: Dexmedetomidine injection
Drug: Sufentanil
Drug: Nalmefene

First Posted Date: 2017-03-30

Last Posted Date: 2021-08-03

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 150

Registration Number: NCT03096730

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Estimation of the ED95 of Intrathecal Hyperbaric Prilocaine 2% With Sufentanyl for Scheduled Cesarean Delivery

Phase 2

Completed

Conditions: Pregnant Women

Interventions: Drug: HB Prilocaine 2%
Drug: HB Prilocaine 2% (varying dose)
Drug: Sufentanil
Drug: Morphine

First Posted Date: 2017-01-30

Last Posted Date: 2020-05-06

Lead Sponsor: Centre Hospitalier Universitaire Saint Pierre

Target Recruit Count: 40

Registration Number: NCT03036384

Locations: 🇧🇪
University Hospital Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels Capital Region, Belgium

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy